News>Pharmaceutical Industries

Pharmaceutical Industries

Advertisement

Lupin Pharmaceuticals is India's most reputed pharma brand; Sun Pharma second

Pharmaceutical Industries

42 essential medicines to be cheaper by up to 15%: NPPA

42 essential medicines to be cheaper by up to 15%: NPPA

FDI up to 74% in brownfield pharma under automatic route

FDI up to 74% in brownfield pharma under automatic route

Give exemption from drug price control for 5 years: Mazumdar-Shaw

Give exemption from drug price control for 5 years: Mazumdar-Shaw

After Pfizer, HC grants relief to Abbott and Macleods

After Pfizer, HC grants relief to Abbott and Macleods

Cipla Q3 net profit rises 4.68% to Rs 343.20 crore

Cipla Q3 net profit rises 4.68% to Rs 343.20 crore

'Withdrawing customs duty may lead to hike in medicine prices'

'Withdrawing customs duty may lead to hike in medicine prices'

Govt in talks with various markets to accept Indian drug norms

Govt in talks with various markets to accept Indian drug norms

USFDA gives Dr Reddy's addl time to respond to warning letter

USFDA gives Dr Reddy's addl time to respond to warning letter

Dr Reddy's Lab Q2 net profit rises 26% to Rs 722 crore

Dr Reddy's Lab Q2 net profit rises 26% to Rs 722 crore

Novartis gets USFDA warning letter for two plants in India

Novartis gets USFDA warning letter for two plants in India

Lupin appoints Martin Mercer as head of Latin American biz

Lupin appoints Martin Mercer as head of Latin American biz

Cipla's Indore plant under USFDA scanner over norms violations

Cipla's Indore plant under USFDA scanner over norms violations

Govt to commission study on impact of FDI in pharma

Govt to commission study on impact of FDI in pharma

Sun Pharma makes tender offer to acquire InSite Vision

Sun Pharma makes tender offer to acquire InSite Vision

Glenmark Pharma eyes US biz to be strong growth driver

Glenmark Pharma eyes US biz to be strong growth driver

Govt assures all help to boost pharma exports

Govt assures all help to boost pharma exports

India defers FTA talks with EU over ban of 700 pharma products

India defers FTA talks with EU over ban of 700 pharma products

SRL lines up Rs 100 crore to add 100 labs by 2016-end

SRL lines up Rs 100 crore to add 100 labs by 2016-end

Hikma buys US generic drugmaker Roxane for $2.65bn

Hikma buys US generic drugmaker Roxane for $2.65bn

NEWS ON ONE CLICK